TheraRadar
← Back
Data updated: Mar 29, 2026

SUNSHINE LAKE PHARMA CO LTD

Infectious DiseaseOncologyRespiratory
Pharma

SUNSHINE LAKE PHARMA CO LTD is a pharmaceutical company focused on Infectious Disease, Oncology, Respiratory.

-
Since
1
Drugs
-
Trials
7
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

MIRABEGRON 2026-01-20
MIRABEGRON 2025-12-29
Manufacturing (CMC)
MIRABEGRON 2025-11-04
MIRABEGRON 2025-09-24
MIRABEGRON 2025-06-30
MIRABEGRON 2025-05-06
MIRABEGRON 2025-01-02
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 45%
0 drugs Phase 3: 1 Phase 2: 5 Phase 1: 14
Oncology 29%
0 drugs Phase 3: 2 Phase 1: 10
Respiratory 18%
0 drugs Phase 3: 1 Phase 2: 1 Phase 1: 5
Metabolic 6%
0 drugs Phase 1: 4
Neurology 2%
0 drugs Phase 1: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

GSK big-pharma
Infectious Disease, Respiratory, Oncology, Neurology
Sanofi big-pharma
Metabolic, Oncology, Infectious Disease, Respiratory
GE HEALTHCARE specialty
Infectious Disease, Neurology, Oncology, Respiratory
Merck big-pharma
Oncology, Infectious Disease, Metabolic
Novo Nordisk big-pharma
Metabolic, Oncology, Infectious Disease, Neurology